Search results for " COVID-19" in Articles / App Notes

Article EMA Confirms Standards for COVID-19 Treatment Evaluations
30, 2020, detailing the agency’s transparency plans for COVID-19 treatments and affirming its commitment to independence in the evaluation of COVID-19 treatments and vaccines. The letter was in respon…

Article EMA Guidance on Changes to COVID-19 Vaccines to Fight Variants
The European Medicines Agency (EMA) has requested that developers determine if their COVID-19 vaccines protect against new virus mutations that have been identified in the United Kingdom, South Africa…

Article Ajinomoto Bio-Pharma Services, CytoDyn in Manufacturing Partnership for COVID-19 Drug
It has been and is currently being administered to COVID-19 patients at New York City area hospitals as part of an emergency investigational new drug (EIND), granted by FDA as part of Phase I, Phase I…

Article Can Vaccine Development Be Safely Accelerated?
Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe. By Cynthia A. Challener MONGKOLCHON - STOCK.ADOBE.COM …

Article Remote Monitoring and Big Data Advance Upstream Automation
The COVID-19 pandemic has only accelerated these trends. Bringing flexibility and increased process intelligence Upstream bioprocess manufacturing is being discussed from many different angles…

Article Strategizing for Rapid Changeovers in Biologics Manufacturing
Through its Operation Warp Speed program for COVID-19 vaccine manufacturing, the US government is paying manufacturers and contract service providers to scale up the manufacture of specific vaccine ca…

Article Genetic Vaccine Platforms Demonstrate Their Potential
…ations with the same or a different vaccine may be applied, which is what we’re seeing in the mRNA COVID-19 vaccines,” he says.    Indeed, while genetic vaccines hold much promise, …

Article Process Development: 2020 Reflections and 2021 Possibilities
Among the many vaccine challenges in relation to the urgency provoked by COVID-19 are safety and the ability to scale up the manufacturing process. Scaling up viral vector and virus manufacturing proc…

Article Single-Use Technologies Are Here to Stay: How Can We Improve Their Supply?
Click here to read more >> The use of single-use technologies has been growing steadily, but supply constraint is a key challenge for the biopharma industry. This article discusses the potenti…

Article Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
The industry is growing rapidly, now even more due to COVID-19. Accelerating this investment will reinforce these commitments,” said Emmanuel Ligner, president and CEO, Cytiva, in the press release. "…

Show All Results

Next Page